Dolutegravir Price Trend and Forecast 2026-2027

Dolutegravir prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 131.8/KG in Q1 to USD 139.7/KG by Q2 as firmer hydroxypyridinone synthesis intermediate costs and recovering HIV antiretroviral treatment programme and first-line integrase inhibitor formulation procurement reversed the brief Q1 2026 pricing correction. Globally, the average rose from USD 96.8/KG in Q1 to USD 102.6/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 100-112/KG is expected, with continued firming on Middle East supply disruptions and growing HIV treatment access, first-line INSTI, and combination antiretroviral therapy sector demand globally.

Dolutegravir is a second-generation HIV-1 integrase strand transfer inhibitor produced by multi-step synthesis from hydroxypyridinone and difluorobenzyl carboxamide building blocks through a polycyclic benzoxazinone bicyclic ring formation sequence to yield the 4,6-bicyclic hydroxypyridinone carboxamide active pharmaceutical ingredient. The compound chelates the divalent magnesium ions in the integrase active site DDE catalytic triad, blocking the strand transfer step of viral cDNA integration into the host genome with a long integrase dissociation half-life providing a high genetic barrier to resistance mutations. Once-daily dosing without food requirements, lower drug-drug interaction potential, and pan-genotypic activity make dolutegravir the preferred first-line agent in WHO, DHHS, and EACS antiretroviral treatment guidelines. The largest pull comes from first-line HIV-1 combination therapy and from Medicines Patent Pool licensed generic manufacturing supplying affordable fixed-dose combinations in low- and middle-income country national HIV programmes. Prevention of mother-to-child HIV transmission and second-line and switch therapy in treatment-experienced patients add further significant demand. Hydroxypyridinone synthesis costs, HIV treatment programme procurement cycles, and regional API production capacity all feed into the price.

Dolutegravir Price Forecast for 2026

The balance of supply and demand for Dolutegravir through H2 2026 leans moderately firm. Hydroxypyridinone synthesis intermediate costs firmed from Middle East chemical supply disruptions. HIV first-line treatment programme, PMTCT, and switch therapy demand are growing with expanding antiretroviral treatment access in developing markets globally.

The main upside risk is synthesis intermediate cost increases alongside accelerating MPP-licensed generic dolutegravir national procurement. The main downside risk is bictegravir and new-generation INSTI competition and continued generic manufacturing cost reduction below the forecast range.

For the Quarter Ending June 2026

Dolutegravir Prices Q2 2026:

• United States: USD 115.7/KG
• China: USD 80.2/KG
• Germany: USD 139.7/KG
• India: USD 108.2/KG

Dolutegravir Prices in the United States

US Dolutegravir prices averaged USD 115.7/KG in Q2 2026, up 6.0% from USD 109.2/KG in Q1 2026. Firmer synthesis intermediate costs and recovering HIV first-line and switch therapy procurement drove consistent buying through the quarter.

Why did the price of Dolutegravir change in Q2 2026 in the United States?

Firmer hydroxypyridinone synthesis intermediate costs raised the API production floor. HIV first-line combination ART, switch therapy tolerability, and treatment-experienced INSTI procurement lifted buying. PMTCT and salvage therapy demand provided additional support near USD 115.7/KG.

Dolutegravir Prices in China

Chinese Dolutegravir prices averaged USD 80.2/KG in Q2 2026, up 6.0% from USD 75.7/KG in Q1 2026, the lowest among the tracked markets. Spring HIV treatment programme and export procurement lifted buying. Firmer domestic synthesis costs raised the floor despite large domestic API capacity.

Why did the price of Dolutegravir change in Q2 2026 in China?

Spring HIV ART programme and export procurement lifted buying. Firmer domestic hydroxypyridinone synthesis costs raised the production floor. Large domestic API capacity kept China the most affordable source near USD 80.2/KG.

Dolutegravir Prices in Germany

German Dolutegravir prices averaged USD 139.7/KG in Q2 2026, up 6.0% from USD 131.8/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European production economics. Recovering HIV first-line and switch therapy demand maintained buying.

Why did the price of Dolutegravir change in Q2 2026 in Germany?

Higher hydroxypyridinone synthesis and energy costs elevated European production economics. Middle East supply disruptions added cost premiums. Recovering HIV first-line ART, switch therapy, and PMTCT procurement maintained buying near USD 139.7/KG.

Dolutegravir Prices in India

Indian Dolutegravir prices averaged USD 108.2/KG in Q2 2026, up 6.0% from USD 102.1/KG in Q1 2026. Growing HIV ART programme, MPP generic export, and switch therapy demand supported buying. Firmer synthesis import costs raised the production floor.

Why did the price of Dolutegravir change in Q2 2026 in India?

Growing HIV first-line ART and MPP generic export procurement lifted buying. Firmer hydroxypyridinone synthesis import costs raised the floor. PMTCT and national HIV programme export demand provided additional support near USD 108.2/KG.

For the Quarter Ending March 2026

Dolutegravir Prices Q1 2026:

• United States: USD 109.2/KG
• China: USD 75.7/KG
• Germany: USD 131.8/KG
• India: USD 102.1/KG

Dolutegravir Prices in the United States

US prices averaged USD 109.2/KG in Q1 2026, easing about 1.9% from Q4 2025. Post-year-end HIV programme and switch therapy procurement moderation and soft synthesis costs eased the market before the Q2 spring ART season recovery.

Why did the price of Dolutegravir change in Q1 2026 in the United States?

Post-year-end HIV first-line and switch therapy procurement moderation reduced buying urgency. Soft hydroxypyridinone synthesis costs eased the production floor. The market eased to USD 109.2/KG before the Q2 HIV programme recovery.

Dolutegravir Prices in China

Chinese prices averaged USD 75.7/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-Lunar New Year HIV programme procurement moderation held the market near USD 75.7/KG.

Why did the price of Dolutegravir change in Q1 2026 in China?

Post-Lunar New Year HIV ART programme procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 75.7/KG before the Q2 HIV programme recovery.

Dolutegravir Prices in Germany

German prices averaged USD 131.8/KG in Q1 2026, easing about 1.9% from Q4 2025. Post-year-end HIV and switch therapy procurement moderation and soft synthesis and energy costs eased the European market near USD 131.8/KG.

Why did the price of Dolutegravir change in Q1 2026 in Germany?

Post-year-end HIV first-line and switch therapy procurement moderation reduced urgency. Soft synthesis and energy costs eased the production floor. The market eased to USD 131.8/KG before the Q2 HIV ART season recovery.

Dolutegravir Prices in India

Indian prices averaged USD 102.1/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-holiday HIV programme procurement moderation and soft synthesis import costs held the market near USD 102.1/KG.

Why did the price of Dolutegravir change in Q1 2026 in India?

Post-holiday HIV ART programme procurement moderation reduced urgency. Soft hydroxypyridinone synthesis import costs eased the floor. The market eased to USD 102.1/KG before the Q2 HIV programme and MPP export recovery.

Quarterly Dolutegravir Price Trends

Global Dolutegravir prices firmed through Q3 and Q4 2025 on HIV programme procurement and INSTI adoption growth, corrected in Q1 2026 on post-year-end moderation, then surged in Q2 2026. The average rose from USD 95.0/KG in Q2 2025 to USD 96.9/KG in Q3 and USD 98.8/KG in Q4, eased to USD 96.8/KG in Q1 2026, then surged to USD 102.6/KG in Q2 2026, a net gain of about 8.0% over the window. Hydroxypyridinone synthesis cost cycles and HIV first-line ART, switch therapy, and MPP procurement drove the seasonal pattern.

What was Dolutegravir Price in 2025?

Dolutegravir prices firmed through 2025 on consistent HIV treatment programme and INSTI first-line adoption demand. The global average opened near USD 91.3/KG in Q1 2025 and closed at USD 98.8/KG in Q4, a full-year gain of about 8.2%. Hydroxypyridinone synthesis cost firming and HIV programme and switch therapy procurement drove the upward trajectory.

Dolutegravir Prices in the United States in 2025

US prices firmed from about USD 107.1/KG in Q1 2025 to USD 111.4/KG by Q4, a gain of 4.0%. Consistent HIV first-line and switch therapy demand maintained the upward trend.

Dolutegravir Prices in China in 2025

Chinese prices firmed from roughly USD 74.2/KG in Q1 2025 to USD 77.2/KG by Q4, a gain of 4.0%. Growing HIV ART programme export and domestic demand drove firming.

Dolutegravir Prices in Germany in 2025

German prices firmed from about USD 129.2/KG in Q1 2025 to USD 134.5/KG by Q4, a gain of 4.1%. Consistent HIV first-line and switch therapy demand and firm synthesis costs supported the market.

Dolutegravir Prices in India in 2025

Indian prices firmed from roughly USD 100.1/KG in Q1 2025 to USD 104.2/KG by Q4, a gain of 4.1%. Growing HIV ART and MPP generic export demand drove consistent firming.

How We Can Help

Expert Market Research: Your Source for Real-Time Dolutegravir Price Intelligence

Expert Market Research tracks Dolutegravir prices continuously across every major producing and consuming region. The team traces causation through hydroxypyridinone synthesis intermediate economics, HIV antiretroviral treatment programme procurement cycles, and regional API production capacity. Contact Expert Market Research today for Dolutegravir pricing data, bespoke market analysis, and strategic procurement advisory.